Annual Operating Expenses
$11.30 M
-$3.46 M-23.41%
31 December 2023
Summary:
Qualigen Therapeutics annual total operating expenses is currently $11.30 million, with the most recent change of -$3.46 million (-23.41%) on 31 December 2023. During the last 3 years, it has risen by +$575.60 thousand (+5.36%). QLGN annual operating expenses is now -52.87% below its all-time high of $23.98 million, reached on 31 December 2021.QLGN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$1.27 M
-$472.20 K-27.13%
30 September 2024
Summary:
Qualigen Therapeutics quarterly total operating expenses is currently $1.27 million, with the most recent change of -$472.20 thousand (-27.13%) on 30 September 2024. Over the past year, it has dropped by -$1.51 million (-54.34%). QLGN quarterly operating expenses is now -83.30% below its all-time high of $7.60 million, reached on 30 June 2021.QLGN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.4% | -54.3% |
| 3 y3 years | +5.4% | -74.5% |
| 5 y5 years | - | +165.1% |
QLGN Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -52.9% | +5.4% | -74.5% | at low |
| 5 y | 5 years | -52.9% | +5.4% | -83.3% | +165.1% |
| alltime | all time | -52.9% | +5.4% | -83.3% | +165.1% |
Qualigen Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.27 M(-27.1%) |
| June 2024 | - | $1.74 M(+22.4%) |
| Mar 2024 | - | $1.42 M(-37.5%) |
| Dec 2023 | $11.30 M(-23.4%) | $2.27 M(-18.2%) |
| Sept 2023 | - | $2.78 M(-22.9%) |
| June 2023 | - | $3.60 M(+35.9%) |
| Mar 2023 | - | $2.65 M(-22.9%) |
| Dec 2022 | $14.76 M | $3.44 M(-1.0%) |
| Sept 2022 | - | $3.47 M(-22.4%) |
| June 2022 | - | $4.47 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $4.90 M(-0.1%) |
| Dec 2021 | $23.98 M(+123.5%) | $4.91 M(-1.2%) |
| Sept 2021 | - | $4.97 M(-34.6%) |
| June 2021 | - | $7.60 M(+16.7%) |
| Mar 2021 | - | $6.51 M(+79.2%) |
| Dec 2020 | $10.73 M | - |
| Sept 2020 | - | $3.63 M(+36.3%) |
| June 2020 | - | $2.67 M(+457.0%) |
| Sept 2019 | - | $478.60 K(-54.8%) |
| June 2019 | - | $1.06 M |
FAQ
- What is Qualigen Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual operating expenses year-on-year change?
- What is Qualigen Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly operating expenses year-on-year change?
What is Qualigen Therapeutics annual total operating expenses?
The current annual operating expenses of QLGN is $11.30 M
What is the all time high annual operating expenses for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual total operating expenses is $23.98 M
What is Qualigen Therapeutics annual operating expenses year-on-year change?
Over the past year, QLGN annual total operating expenses has changed by -$3.46 M (-23.41%)
What is Qualigen Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of QLGN is $1.27 M
What is the all time high quarterly operating expenses for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly total operating expenses is $7.60 M
What is Qualigen Therapeutics quarterly operating expenses year-on-year change?
Over the past year, QLGN quarterly total operating expenses has changed by -$1.51 M (-54.34%)